Efficacy of Bosentan in Digital Ischemic Ulcers

被引：12
|
作者：
Todoli Parra, Jose A. [1 ]
Miralles Hernandez, Manuel [2 ]
Arrebola Lopez, Manuel A. [2 ]
机构：
[1] Hosp Univ La Fe, Dept Internal Med, Valencia 46009, Spain
[2] Hosp Univ La Fe, Angiol & Vasc Surg Dept, Valencia 46009, Spain
来源：
ANNALS OF VASCULAR SURGERY | 2010年 / 24卷 / 05期
关键词：
BUERGERS-DISEASE; THROMBOANGIITIS;
D O I：
10.1016/j.avsg.2010.03.011
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Thromboangiitis obliterans (also known as Buerger's disease) is an inflammatory vascular disorder that affects small and medium-sized arteries and veins in the extremities. There is no specific treatment and the only effective intervention is absolute cessation of tobacco use. Endothelial dysfunction appears to be of relevance to this condition and a report has even found that high serum levels of endothelin correlate with the presence of necrosis. We report two cases of digital necrosis showing a very satisfactory response to treatment with bosentan, a dual endothelin receptor antagonist.
引用
收藏
页码：690.e1 / 690.e4
页数：4
相关论文
共 50 条
  • [21] Long-term efficacy and safety of Bosentan in the treatment of ischemic digital ulcers, Raynaud's phenomenon and cutaneous fibrosis in patients with systemic sclerosis.
    Alegre-Sancho, JJ
    Fernández-Llanio, N
    Román-Ivorra, JA
    Chalmeta-Verdejo, C
    Fernández-Carballido, CF
    Abad-Franch, L
    Alcañiz-Escandell, C
    Hortal-Alonso, R
    Ivorra-Cortés, J
    Muñoz-Gil, S
    Pareja-Lázaro, MA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S590 - S590
  • [22] Bosentan for treatment of active digital ulcers in patients with systemic sclerosis
    Launay, D
    Diot, É
    Pasquier, É
    Mouthon, L
    Boullanger, N
    Fain, O
    Jego, P
    Carpentier, P
    Hatron, PY
    Hachulla, É
    PRESSE MEDICALE, 2006, 35 (04): : 587 - 592
  • [23] BOSENTAN FOR DIGITAL ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS: SINGLECENTER EXPERIENCE
    Kucuksahin, O.
    Ates, A.
    Ilgrn, U.
    Ozturk, B.
    Kinikli, G.
    Turgay, M.
    Duzgun, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S79 - S79
  • [24] Effect of a sequential therapy of bosentan and iloprost versus a monotherapy with bosentan in the treatment of scleroderma related digital ulcers
    Hafner, F.
    Thomas, G.
    Froehlich, H.
    Steidl, K.
    Brodmann, M.
    INTERNATIONAL ANGIOLOGY, 2011, 30 (05) : 493 - 495
  • [25] Bosentan For Digital Ulcers in Patients With Systemic Sclerosis: Single Center Experience
    Kucuksahin, Orhan
    Yildizgoren, Mustafa Turgut
    Gerede, Demet Menekse
    Maras, Yuksel
    Erten, Sukran
    ARCHIVES OF RHEUMATOLOGY, 2016, 31 (03): : 229 - 233
  • [26] Bosentan reduces the number of new digital ulcers in patients with systemic sclerosis
    Seibold, J. R.
    Matucci-Cerinic, M.
    Denton, C. P.
    Furst, D. E.
    Mayes, M. D.
    Kramer, F.
    Morganti, A.
    Korn, J. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 90 - 90
  • [27] Bosentan reduces the number of new digital ulcers in patients with systemic sclerosis
    Matucci-Cerinic, M.
    Denton, C. P.
    Furst, D. E.
    Mayes, M. D.
    Morganti, A.
    Kramer, F.
    Korn, J. H.
    Seibold, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A46 - A47
  • [28] Efficacy of Bosentan in treatment of refractory sclerodermic bone prominences skin ulcers
    Richetta, A. G.
    Mattozzi, C.
    Maiani, E.
    D'Epiro, S.
    Cimillo, M.
    Carboni, V.
    Giancristoforo, S.
    Calvieri, S.
    CLINICA TERAPEUTICA, 2008, 159 (05): : 317 - 319
  • [29] DIGITAL PERIARTERIAL SYMPATHECTOMY FOR ISCHEMIC DIGITAL PAIN AND ULCERS
    ELGAMMAL, TA
    BLAIR, WF
    JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME, 1991, 16B (04): : 382 - 385
  • [30] Digital artery sympathectomy for ischemic digital pain and ulcers/
    Sakuma, T
    Homma, S
    Okumura, J
    Azuma, H
    PROCEEDINGS OF THE 9TH CONGRESS OF THE INTERNATIONAL FEDERATION OF SOCIETIES FOR SURGERY OF THE HAND, 2004, : 527 - 530
12345